Trials / Completed
CompletedNCT05500053
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Rational Vaccines Inc · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Determine the baseline characteristics of patients who have recurrent symptomatic genital herpetic disease Determine the acceptance to patients of clinical trial procedures Determine interest in participation in genital herpes vaccine trials
Conditions
Timeline
- Start date
- 2022-08-03
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-08-12
- Last updated
- 2023-01-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05500053. Inclusion in this directory is not an endorsement.